milademetan Report issue

Small molecule Experimental
AACT PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CC1(C)CCC2(CC1)N[C@@H](C(=O)N[C@@H]1CC[C@@H](C(N)=O)OC1)[C@H](c1ccnc(Cl)c1F)[C@]21C(=O)Nc2ccc(Cl)cc21.Cc1ccc(S(=O)(=O)O)cc1
  • InChIKey: IMQCYLLYCWTAHP-LINJWFRASA-N
  • Mol. Mass: 790.74
  • ALogP: 3.96
  • ChEMBL Molecules:
    milademetan tosylate  
    milademetan  
More Chemistry

Pharmacology

Alternative names

ds-3032b

Organizations (6)

Research & Development (6)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (26)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (26)


 

Adenocarcinoma of Lung (Phase 2)

Adrenocortical Carcinoma (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Renal Cell (Phase 1/Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Cholangiocarcinoma (Phase 2)

Gene Amplification (Phase 2)

Heart Diseases (Phase 1)

Leukemia, Myeloid, Acute (Phase 1/Phase 2)

Liposarcoma (Phase 3)

Lymphoma (Phase 1)

Melanoma (Phase 2)

Mesothelioma (Phase 1/Phase 2)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Pharmacokinetics (Early Phase 1)

Sarcoma (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 2)

Testicular Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 13
  • # of Trial Organizations: 6

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue